Response to: Correspondence on 'Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fractures' by Dai et al.

IF 20.3 1区医学 Q1 RHEUMATOLOGY

Annals of the Rheumatic Diseases Pub Date : 2025-07-01 Epub Date: 2025-05-08 DOI:10.1016/j.ard.2025.04.010

Barbara Hauser, Andrew Merriman, Jonathan Foley, Janardhana Golla, Euan McRorie, Stuart H Ralston

引用次数: 0

查看原文本刊更多论文

对Dai等人关于“甲氨蝶呤继续治疗增加下肢不全性骨折患者骨折风险”的回应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of the Rheumatic Diseases 医学-风湿病学

CiteScore

35.00

自引率

9.90%

发文量

3728

审稿时长

1.4 months

期刊介绍： Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.